Home › Funds › FORMULA GROWTH LTD › EVH
FORMULA GROWTH LTD position in EVH
EVOLENT HEALTH INC · Consumer Discretionary
FORMULA GROWTH LTD reported holding 578,000 shares of EVH (EVOLENT HEALTH INC) in its Q3 2026 13F filing — a position valued at US$2.0M, representing 0.78% of its reported portfolio and ranking #40 among its reported holdings. FORMULA GROWTH LTD has disclosed EVH holdings in 8 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How FORMULA GROWTH LTD's EVH position evolved
FORMULA GROWTH LTD first disclosed a stake in EVH in Q3 2023 at 296,901 shares (US$8.1M). The position peaked in Q4 2023 at 253,001 shares, worth US$8.4M. Across 8 filings, FORMULA GROWTH LTD increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 578,000 shares valued at US$2.0M — an increase of 93,000 shares quarter over quarter.. Notable position changes include a 31% trim in Q2 2024 (shares rose 48% over the following quarter), a 126% increase in Q2 2026 (shares fell 36% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 296.90K | $8.08M | New |
| Q4 2023 | 253.00K | $8.36M | Reduce |
| Q1 2024 | 247.95K | $8.13M | Reduce |
| Q2 2024 | 171.55K | $3.28M | Reduce |
| Q3 2024 | 186.93K | $5.29M | Add |
| Q1 2026 | 215.00K | $490.20K | New |
| Q2 2026 | 485.00K | $2.63M | Add |
| Q3 2026 | 578.00K | $2.02M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EVH and 13F data
EVH (EVOLENT HEALTH INC) is a Consumer Discretionary company. 8 other funds we track also report a position in EVH — the largest reported positions include CADIAN CAPITAL MANAGEMENT, LP (US$58.6M), DeepCurrents Investment Group LLC (US$21.7M), Rubicon Founders LLC (US$19.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EVH
- CADIAN CAPITAL MANAGEMENT, LP 10.81M sh · $58.61M · Q2 2026
- DeepCurrents Investment Group LLC 29.99M sh · $21.70M · Q3 2026
- Rubicon Founders LLC 5.64M sh · $19.69M · Q3 2026
- PenderFund Capital Management Ltd. 23.37M sh · $19.02M · Q2 2026
More on FORMULA GROWTH LTD
FAQ
How long has FORMULA GROWTH LTD held EVH?
FORMULA GROWTH LTD has disclosed EVH holdings in 8 of the last 13 reported quarters, going back to Q3 2023.
What is FORMULA GROWTH LTD's current position in EVH?
As of Q3 2026, FORMULA GROWTH LTD holds 578.00K shares of EVH (EVOLENT HEALTH INC), valued at $2.02M, representing 0.78% of its reported portfolio and ranking #40.
Has FORMULA GROWTH LTD been buying or selling EVH?
In the latest 13F filing (Q3 2026), FORMULA GROWTH LTD increased its position in EVH. The position peaked in Q4 2023 at 253.00K shares.
Which other funds hold EVH?
Other major institutional holders of EVH include CADIAN CAPITAL MANAGEMENT, LP, DeepCurrents Investment Group LLC, Rubicon Founders LLC, among 8 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.